Does new onset and pre-existing atrial fibrillation predict mortality in COVID-19 patients?

BACKGROUND: Coronavirus Disease-2019 (COVID-19), caused by Severe Acute Respiratory Syndrome-Coronavirus-2, still remains prevalent and severe. We aimed to evaluate the effects of pre-existing atrial fibrillation and new-onset atrial fibrillation (NOAF) on the clinical severity and mortality of COVI...

Descripción completa

Detalles Bibliográficos
Autores principales: Aydemir, Selim, Aksakal, Emrah, Aydınyılmaz, Faruk, Gülcü, Oktay, Saraç, İbrahim, Aydın, Sidar Şiyar, Doğan, Remziye, Lazoğlu, Merve, Kalkan, Kamuran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261123/
https://www.ncbi.nlm.nih.gov/pubmed/35796916
http://dx.doi.org/10.1186/s43044-022-00291-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261123/
https://www.ncbi.nlm.nih.gov/pubmed/35796916
http://dx.doi.org/10.1186/s43044-022-00291-9

Ejemplares similares